학술논문
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vsaspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
Document Type
Article
Author
Vranckx, Pascal; Valgimigli, Marco; Jüni, Peter; Hamm, Christian; Steg, Philippe Gabriel; Heg, Dik; van Es, Gerrit Anne; McFadden, Eugene P; Onuma, Yoshinobu; van Meijeren, Cokky; Chichareon, Ply; Benit, Edouard; Möllmann, Helge; Janssens, Luc; Ferrario, Maurizio; Moschovitis, Aris; Zurakowski, Aleksander; Dominici, Marcello; Van Geuns, Robert Jan; Huber, Kurt; Slagboom, Ton; Serruys, Patrick W; Windecker, Stephan; Abdellaoui, Mohamed; Adlam, David; Akin, Ibrahim; Albarran Gonzalez-Trevilla, Agustin; Almeida, Manuel; Alves Lemos Neto, Pedro; Aminian, Adel; Anderson, Richard; Andreae, Rick; Angioi, Michael; Asano, Taku; Barbato, Emanuele; Barlis, Peter; Barraud, Pascal; Benit, Edouard; Bertrand, Olivier; Beygui, Farzin; Bolognese, Leonardo; Botelho, Roberto; Bouwman, Coby; Bressers, Marco; Brunel, Philippe; Buszman, Pawel; Buysschaert, Ian; Canas da Silva, Pedro; Carrie, Didier; Cequier, Angel; Chichareon, Ply; Chin Chang, Chun; Chowdhary, Saqib; Collet, Carlos; Colombo, Antonio; Cotton, James; Cruz Ferreira, Rui; Curello, Salvatore; Curzen, Nick; de Bot, Judith; de Vreede, Tone; Delle Karth, Georg; Dijksma, Lynn; Dominici, Marcello; Édes, István; Eeckhout, Eric; Eitel, Ingo; Faluközy, József; Fath-Ordoubadi, Farzin; Ferrario, Maurizio; Fontos, Geza; Francisco Diaz, Jose; Freitas Quintella, Edgard; Frey, Bernhard; Friedrich, Guy; Galasko, Gavin; Galuszka, Grzegorz; Gama Ribeiro, Vasco; Garg, Scot; Gargiulo, Giuseppe; Geisler, Tobias; Gelev, Valeri; Ghandilyan, Art; Goicolea, Javier; Gori, Tommaso; Gragnano, Felice; Guimarães, Ana; Hamm, Christian; Haude, Michael; Heg, Dik; Heijke, Pieter; Hernández Antolin, Rosa Ana; Hildick-Smith, David; Hillen, Dorien; Hoekman, Ina; Hofma, Sjoerd; Holmvang, Lene; Hoole, Stephen; Horváth, Iván; Huber, Kurt; Hugense, Annemarie; Ibrahim, Karim; Iñiguez, Andres; Isaaz, Karl; Jambrik, Zoltán; Janssens, Luc; Jasionowicz, Pawel; Jonk, Judith; Jung, Werner; Jüni, Peter; Katagiri, Yuki; Kogame, Norihiro; Koh, Tian Hai; Koning, René; Konteva, Mariana; Kőszegi, Zsolt; Krackhardt, Florian; Kreuger, Yvonne; Kukreja, Neville; Ladan, Boudijn; Lantelme, Pierre; Leandro, Sergio; Leibundgut, Gregor; Liebetrau, Christoph; Lindeboom, Wietze; Macaya Miguel, Carlos; Mach, François; Magro, Michael; Maillard, Luc; Manavifar, Negar; Mauri, Laura; McFadden, Eugene; Merkely, Bela; Miyazaki, Yosuke; Młodziankowski, Adam; Moccetti, Tiziano; Modolo, Rodrigo; Möllman, Helge; Morelle, Jean-François; Moschovitis, Aris; Munndt Ottesen, Michael; Muurling, Martin; Naber, Christoph Kurt; Neumann, Franz-Josef; Oldroyd, Keith; Ong, Paul; Onuma, Yoshinobu; Palsrok, Sanne; Petrov, Ivo; Plante, Sylvain; Prokopczuk, Janusz; Rademaker-Havinga, Tessa; Raffel, Christopher; Rensing, Benno; Roffi, Marco; Royaards, Kees-Jan; Sabate, Manel; Schächinger, Volker; Seidler, Tim; Serra Peñaranda, Antonio; Serruys, Patrick; Sikarulidze, Lali; Slagboom, Ton; Soliman, Osama I; Sousa, Amanda; Spitzer, Ernest; Stables, Rod; Steg, Gabriel; Steinwender, Clemens; Subkovas, Eduardas; Suryapranata, Harry; Takahashi, Kuniaki; Talwar, Suneel; Teiger, Emmanuel; ter Weele, Addy; Teurlings, Eva; Thury, Attila; Tijssen, Jan; Tonev, Gincho; Trendafilova-Lazarova, Diana; Tumscitz, Carlo; Umans, Victor; Ungi, Imre; Valkov, Veselin; van der Harst, Pim; van Geuns, Robert Jan; van Meijeren, Cokky; Vassilev, Dobrin; Velchev, Vasil; Velthuizen, Esther; Verheugt, Freek; Vlcek, Natalia; vom Dahl, Jürgen; Vrolix, Mathias; Walsh, Simon; Werner, Nikos; Windecker, Stephan; Witsenburg, Maarten; Zaman, Azfar; Żmudka, Krzysztof; Zrenner, Bernhard; Zurakowski, Aleksander; Zweiker, Robert
Source
The Lancet; September 2018, Vol. 392 Issue: 10151 p940-949, 10p
Subject
Language
ISSN
01406736; 1474547X
Abstract
We hypothesised that ticagrelor, in combination with aspirin for 1 month, followed by ticagrelor alone, improves outcomes after percutaneous coronary intervention compared with standard antiplatelet regimens.